| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |